Outcomes by antibiotic use in participants with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study.
暂无分享，去创建一个
K. Rau | S. Oh | P. Potemski | J. Blanc | N. Rokutanda | D. Oh | V. Ostwal | B. Tan | A. He | E. Sezer | Hidenori Takahashi | E. Sirachainan | T. Suksombooncharoen | M. Chen | Junhe Li | G. Cohen | M. Żotkiewicz